Medicare Enrolled
Dr. Erin Fleener, M.D.
Hematology & Oncology · Bryan, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fleener from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fleener?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fleener
Dr. Erin Fleener is a hematology & oncology specialist in Bryan, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fleener performed 153,105 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fleener received a total of $11,809 from 88 pharmaceutical and/or device companies across 424 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fleener is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in TX
$11,809 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗153,105
Medicare services
Top 2% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,460 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 20,700 | $43 | $100 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
19,870 | $0 | $5 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,750 | $1 | $2 |
| Paclitaxel chemotherapy injection | 12,574 | $0 | $10 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,800 | $6 | $30 |
| Denosumab injection (Prolia/Xgeva) | 8,580 | $18 | $45 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
6,336 | $25 | $50 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,844 | $0 | $32 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,800 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,320 | $6 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,092 | $8 | $16 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,010 | $1 | $55 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,689 | $2 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,636 | $8 | $65 |
| Anti-nausea injection (ondansetron/Zofran) | 1,549 | $0 | $15 |
| Injection, leucovorin calcium, per 50 mg | 1,397 | $3 | $20 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
831 | $22 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
817 | $90 | $180 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
752 | $100 | $300 |
| Injection, irinotecan, 20 mg | 643 | $2 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
617 | $137 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
597 | $11 | $100 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 572 | $3 | $30 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
548 | $2 | $115 |
| Injection, potassium chloride, per 2 meq | 490 | $0 | $2 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
480 | $96 | $575 |
| Injection, atropine sulfate, 0.01 mg | 450 | $0 | $1 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
438 | $50 | $240 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
291 | $21 | $140 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
241 | $12 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
235 | $59 | $125 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
212 | $2 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
179 | $47 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
166 | $1 | $20 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
160 | $6 | $170 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
150 | $98 | $300 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
120 | $1 | $240 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
114 | $25 | $90 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
98 | $19 | $90 |
| New patient office visit, complex (60-74 min) | 84 | $168 | $350 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
82 | $21 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
69 | $56 | $180 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
68 | $15 | $80 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
54 | $1 | $15 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 48 | $390 | $800 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $10 | $115 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 23 | $20 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $30 | $52 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $119 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
29.3% high complexity
67.0% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,809
Total received (2018-2024)
Avg $1,687/year across 7 years
Top 29% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
424
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,557
2023
$1,879
2022
$1,406
2021
$1,642
2020
$570
2019
$1,567
2018
$2,188
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$312
Janssen Biotech, Inc.
$299
Daiichi Sankyo Inc.
$176
Incyte Corporation
$160
Takeda Pharmaceuticals U.S.A., Inc.
$144
Tactile Systems Technology Inc
$115
INTUITIVE SURGICAL, INC.
$111
AstraZeneca Pharmaceuticals LP
$96
Tempus AI, Inc
$85
Amneal Pharmaceuticals LLC
$85
Astellas Pharma US Inc
$74
ABBVIE INC.
$55
Dendreon Pharmaceuticals LLC
$55
PFIZER INC.
$47
ARRAY BIOPHARMA INC
$47
Stemline Therapeutics Inc.
$43
Eisai Inc.
$41
GlaxoSmithKline, LLC.
$37
Tolmar, Inc.
$33
Lilly USA, LLC
$32
Iovance Biotherapeutics, Inc.
$31
Celgene Corporation
$30
SpringWorks Therapeutics, Inc.
$29
Verity Pharmaceuticals Inc.
$28
Pharmacosmos Therapeutics Inc.
$27
Immunocore Limited
$26
PharmaEssentia USA Corporation
$26
Deciphera Pharmaceuticals Inc.
$25
Merck Sharp & Dohme LLC
$23
Agios Pharmaceuticals, Inc.
$23
Ipsen Biopharmaceuticals, Inc
$22
Mirati Therapeutics, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
Karyopharm Therapeutics Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SOBI, INC
$20
Regeneron Healthcare Solutions, Inc.
$19
Genmab U.S., Inc.
$18
Coherus Biosciences Inc.
$18
BeiGene USA, Inc.
$16
Genentech USA, Inc.
$15
Myriad Genetic Laboratories, Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$14
Top 3 companies account for 30.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,532
Janssen Biotech, Inc.
$841
Novartis Pharmaceuticals Corporation
$747
E.R. Squibb & Sons, L.L.C.
$578
Amgen Inc.
$479
Incyte Corporation
$449
Helsinn Therapeutics (U.S.), Inc.
$408
GlaxoSmithKline, LLC.
$339
Lilly USA, LLC
$339
Ipsen Biopharmaceuticals, Inc
$325
Genentech USA, Inc.
$315
PFIZER INC.
$281
Merck Sharp & Dohme Corporation
$271
Celgene Corporation
$241
Myriad Genetic Laboratories, Inc.
$234
Daiichi Sankyo Inc.
$229
Astellas Pharma US Inc
$209
Takeda Pharmaceuticals U.S.A., Inc.
$208
Taiho Oncology, Inc.
$179
Merck Sharp & Dohme LLC
$141
Tactile Systems Technology Inc
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
GENZYME CORPORATION
$118
Eisai Inc.
$112
Dendreon Pharmaceuticals LLC
$112
INTUITIVE SURGICAL, INC.
$111
Coherus Biosciences Inc.
$103
ARRAY BIOPHARMA INC
$103
Gilead Sciences, Inc.
$103
Seagen Inc.
$98
ASD SPECIALTY HEALTHCARE, LLC
$97
Stemline Therapeutics Inc.
$91
TerSera Therapeutics LLC
$91
Tempus AI, Inc
$85
Amneal Pharmaceuticals LLC
$85
MorphoSys, US Inc.
$76
Deciphera Pharmaceuticals Inc.
$74
BeiGene USA, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$71
EMD Serono, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$64
Foundation Medicine, Inc.
$61
Clovis Oncology, Inc.
$61
TESARO, Inc.
$60
Karyopharm Therapeutics Inc.
$56
ABBVIE INC.
$55
Spectrum Pharmaceuticals Inc.
$55
IntrinsiQ Specialty Solutions, Inc.
$54
PUMA BIOTECHNOLOGY, INC.
$54
Octapharma USA, Inc.
$53
Genmab U.S., Inc.
$46
Pharmacosmos Therapeutics Inc.
$46
AMAG Pharmaceuticals, Inc.
$46
Mirati Therapeutics, Inc.
$41
TAIHO ONCOLOGY, INC.
$41
Janssen Pharmaceuticals, Inc
$40
EISAI INC.
$39
Seattle Genetics, Inc.
$34
Tolmar, Inc.
$33
Iovance Biotherapeutics, Inc.
$31
SpringWorks Therapeutics, Inc.
$29
Verity Pharmaceuticals Inc.
$28
AVEO Pharmaceuticals, Inc.
$27
Immunocore Limited
$26
ImmunoGen, Inc.
$26
PharmaEssentia USA Corporation
$26
Celltrion USA Inc.
$25
Teva Pharmaceuticals USA, Inc.
$24
Agios Pharmaceuticals, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$22
Puma Biotechnology, Inc.
$21
AbbVie Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SOBI, INC
$20
Novocure Inc.
$20
Blueprint Medicines Corporation
$19
Aveo Pharmaceuticals, Inc.
$19
Acceleron Pharma, Inc.
$19
Epizyme, Inc.,
$19
ADMA BioManufacturing LLC
$19
SERVIER PHARMACEUTICALS LLC
$18
Rigel Pharmaceuticals, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Heron Therapeutics, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$14
ADC Therapeutics America, Inc.
$13
EAGLE PHARMACEUTICALS, INC.
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · Alecensa · Aliqopa · Amtagvi · Avastin · BELEODAQ · BELRAPZO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · Da Vinci Surgical System · ELIGARD · ELIQUIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Enhertu · Epkinly · Erleada · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONFOCUS · FOUNDATIONONE · FRUZAQLA · Flexitouch Plus · GAVRETO · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUMIZYME · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · Oncology · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PREVNAR 13 · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · ROLVEDON · Reblozyl · Revlimid · Rituxan Hycela · Rubraca · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TRUSELTIQ · TUKYSA · Tavalisse · Trelstar · Trodelvy · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZOLADEX · Zoladex · myChoice CDx · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
7
County median income
$58,388
Nearest hospital to ZIP centroid (approximate)
CHI ST JOSEPH HEALTH REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fleener is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fleener experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Fleener performed 23,460 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fleener receive payments from pharmaceutical companies?
Yes. Dr. Fleener received a total of $11,809 from 88 companies across 424 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fleener's costs compare to other hematology & oncology specialists in Bryan?
Dr. Fleener's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fleener) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bryan
Browse hematology & oncology specialists in Bryan ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology